Associations between parameters of nutritional status and disease activity in patients with rheumatoid arthritis

Polskie Archiwum Medycyny Wewnetrznej

Volumn 121, Issue 4, 2011, Pages 122-128

  Targońska Stȩpniak, Bozena ^a   Majdan, Maria ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Disease activity; Nutritional status; Prognosis; Rheumatoid arthritis; Rheumatoid cachexia

Indexed keywords

ADALIMUMAB; C REACTIVE PROTEIN; CHLOROQUINE; CHOLESTEROL; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; FIBRINOGEN; GLUCOSE; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INFLIXIMAB; LEFLUNOMIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METHOTREXATE; PREDNISONE; RITUXIMAB; SALAZOSULFAPYRIDINE; SERUM ALBUMIN; TRIACYLGLYCEROL;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHRONIC INFLAMMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; FIBRINOGEN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GRIP STRENGTH; HAND GRIP; HEMOGLOBIN BLOOD LEVEL; HUMAN; JOINT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL PARAMETERS; NUTRITIONAL STATUS; PHYSICAL DISABILITY; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; SKINFOLD THICKNESS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 79955102889     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Roubenoff R. Rheumatoid cachexia: a complication of rheumatoid arthritis moves into the 21st century. Arthritis Res Ther. 2009; 11: 108.
2. Summers GD, Deighton CM, Rennie MJ, et al. Rheumatoid cachexia: a clinical perspective. Rheumatology. 2008; 47: 1124-1131. (Pubitemid 352038214)
3. Summers GD, Metsios GS, Stavropoulos-Kalinoglou A, et al. Rheumatoid cachexia and cardiovascular disease. Nat Rev Rheumatol. 2010; 6: 445-451.
4. Engvall IL, Elkan AC, Tengstrand B, et al. Cachexia in rheumatoid arthritis is associated with inflammatory activity, physical disability and low bioavailable insulin-like growth factor. Scand J Rheumatol. 2008; 37: 321-328.
5. Walsmith J, Abad L, Kehayias J, et al. Tumor necrosis factor-α production is associated with less body cell mass in women with rheumatoid arthritis. J Rheumatol. 2004; 31: 23-29. (Pubitemid 38067517)
6. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988; 31, 315-324.
7. Prevoo ML, vant't Hof MA, Kuper HH, et al. Modified disease activity scores that includes twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995; 38: 44-48.
8. Pincus T, Sokka T, Kautiainen H. Further development of a physical function scale on a MDHAQ.[corrected] for standard care of patients with rheumatic diseases. J Rheumatol. 2005; 32: 1432-1439. (Pubitemid 41113961)
9. Kremers HM, Nicola PJ, Crowson CS, et al. Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis. Arthritis Rheum. 2004; 50: 3450-3457. (Pubitemid 39488669)
10. Gómez-Vaquero C, Nolla JM, Fiter J, et al. Nutritional status in patients with rheumatoid arthritis. Joint Bone Spine. 2001; 68: 403-409. (Pubitemid 32988526)
11. Kaufmann J, Kielstein V, Kilian S, et al. Relation between body mass index and radiological progression in patients with rheumatoid arthritis. J Rheumatol. 2003; 30: 2350-2355. (Pubitemid 37413892)
12. Giles JT, Bartlett SJ, Andersen R, et al. Association of body fat with C-reactive protein in rheumatoid arthritis. Arthritis Rheum. 2008; 58: 2632-2641.
13. Stenvinkel P, Heimbürger O, Lindholm B, et al. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant. 2000; 15: 953-960. (Pubitemid 30410364)
14. Rall LC, Roubenoff R. Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions. Rheumatology. 2004; 43: 1219-1223. (Pubitemid 39359292)
15. Heimbürger O, Qureshi AR, Blaner WS, et al. Hand-grip muscle strength, lean body mass, and plasma proteins as markers of nutritional status in patients with chronic renal failure close to start of dialysis therapy. Am J Kidney Dis. 2000; 36: 1213-1225.
16. Choy E, Sattar N. Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions. Ann Rheum Dis. 2009; 68: 460-469.
17. Panaszek B, Machaj Z, Bogacka E, et al. Chronic disease in the elderly: a vital rationale for the revival of internal medicine. Pol Arch Med Wewn. 2009; 119: 248-254.
18. Elkan AC, Håkansson N, Frostegård J, et al. Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther. 2009; 11: R37.
19. Escalante A, Haas RW, del Rincón I. Paradoxical effect of body mass index on survival in rheumatoid arthritis. Arch Intern Med. 2005; 165: 1624-1629.
20. Metsios GS, Stavropoulos-Kalinoglou A, Douglas KM, et al. Blockade of tumour necrosis factor-alpha in rheumatoid arthritis: effects on components of rheumatoid cachexia. Rheumatology (Oxford). 2007; 46: 1824-1827. (Pubitemid 350168299)
21. Marcora SM, Chester KR, Mittal G, et al. Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis. Am J Clin Nutr. 2006; 84: 1463-1472. (Pubitemid 44912832)
22. Bijlsma JW. Optimal treatment of rheumatoid arthritis: EULAR recommendations for clinical practice. Pol Arch Med Wewn. 2010; 120: 347-353.